{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:46:02Z","timestamp":1777589162681,"version":"3.51.4"},"publisher-location":"Berlin, Heidelberg","reference-count":191,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642287107","type":"print"},{"value":"9783642287114","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/7854_2011_165","type":"book-chapter","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T13:15:05Z","timestamp":1319721305000},"page":"117-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular Imaging and the Neuropathologies of Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Paul","family":"Cumming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Borghammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,28]]},"reference":[{"issue":"10","key":"165_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20(10):1255\u20131263","journal-title":"Mov Disord"},{"issue":"5","key":"165_CR2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archneur.1993.00540050026010","volume":"50","author":"A Antonini","year":"1993","unstructured":"Antonini A, Leenders KL, Reist H, Thomann R, Beer HF, Locher J (1993) Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. Arch Neurol 50(5):474\u2013480","journal-title":"Arch Neurol"},{"issue":"7","key":"165_CR3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/WNL.44.7.1325","volume":"44","author":"A Antonini","year":"1994","unstructured":"Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL (1994) [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson\u2019s disease: influence of l-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 44(7):1325\u20131329","journal-title":"Neurology"},{"issue":"1","key":"165_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mds.870120107","volume":"12","author":"A Antonini","year":"1997","unstructured":"Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson\u2019s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12(1):33\u201338","journal-title":"Mov Disord"},{"issue":"2","key":"165_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mds.870130212","volume":"13","author":"A Antonini","year":"1998","unstructured":"Antonini A, Kazumata K, Feigin A, Mandel F, Dhawan V, Margouleff C, Eidelberg D (1998) Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord 13(2):268\u2013274","journal-title":"Mov Disord"},{"issue":"5","key":"165_CR6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","volume":"164","author":"I Araki","year":"2000","unstructured":"Araki I, Kitahara M, Oida T, Kuno S (2000) Voiding dysfunction and Parkinson\u2019s disease: urodynamic abnormalities and urinary symptoms. J Urol 164(5):1640\u20131643","journal-title":"J Urol"},{"issue":"Pt 10","key":"165_CR7","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/brain\/awl162","volume":"129","author":"K Asanuma","year":"2006","unstructured":"Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006) Network modulation in the treatment of Parkinson\u2019s disease. Brain 129(Pt 10):2667\u20132678","journal-title":"Brain"},{"issue":"10","key":"165_CR8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21(10):1133\u20131145","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"165_CR9","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","volume":"71","author":"N Aubin","year":"1998","unstructured":"Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71(4):1635\u20131642","journal-title":"J Neurochem"},{"issue":"1","key":"165_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","volume":"16","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Willemsen AT, Doorduin J, de Vries EF, Dierckx RA, Leenders KL (2010) [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease? Parkinsonism Relat Disord 16(1):57\u201359","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"165_CR11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/mds.1212","volume":"16","author":"G Berding","year":"2001","unstructured":"Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH (2001) Resting regional cerebral glucose metabolism in advanced Parkinson\u2019s disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16(6):1014\u20131022","journal-title":"Mov Disord"},{"issue":"2","key":"165_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(86)90066-2","volume":"72","author":"B Berger","year":"1986","unstructured":"Berger B, Trottier S, Gaspar P, Verney C, Alvarez C (1986) Major dopamine innervation of the cortical motor areas in the cynomolgus monkey. A radioautographic study with comparative assessment of serotonergic afferents. Neurosci Lett 72(2):121\u2013127","journal-title":"Neurosci Lett"},{"issue":"2","key":"165_CR13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/jn.1994.72.2.507","volume":"72","author":"H Bergman","year":"1994","unstructured":"Bergman H, Wichmann T, Karmon B, DeLong MR (1994) The primate subthalamic nucleus II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72(2):507\u2013520","journal-title":"J Neurophysiol"},{"issue":"3","key":"165_CR14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1212\/WNL.52.3.541","volume":"52","author":"NI Bohnen","year":"1999","unstructured":"Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE (1999) Motor correlates of occipital glucose hypometabolism in Parkinson\u2019s disease without dementia. Neurology 52(3):541\u2013546","journal-title":"Neurology"},{"issue":"12","key":"165_CR15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","volume":"23","author":"I Boileau","year":"2008","unstructured":"Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ (2008) Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB. Mov Disord 23(12):1776\u20131780","journal-title":"Mov Disord"},{"issue":"2\u20133","key":"165_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(84)90238-3","volume":"99","author":"B Bokobza","year":"1984","unstructured":"Bokobza B, Ruberg M, Scatton B, Javoy-Agid F, Agid Y (1984) [3H]spiperone binding, dopamine and HVA concentrations in Parkinson\u2019s disease and supranuclear palsy. Eur J Pharmacol 99(2\u20133):167\u2013175","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"165_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuroimage.2007.12.057","volume":"40","author":"P Borghammer","year":"2008","unstructured":"Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A (2008) Normalization in PET group comparison studies\u2014the importance of a valid reference region. Neuroimage 40(2):529\u2013540","journal-title":"Neuroimage"},{"issue":"4","key":"165_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuroimage.2009.03.021","volume":"46","author":"P Borghammer","year":"2009a","unstructured":"Borghammer P, Aanerud J, Gjedde A (2009a) Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46(4):981\u2013988","journal-title":"Neuroimage"},{"issue":"4","key":"165_CR19","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.neuroimage.2009.05.040","volume":"47","author":"P Borghammer","year":"2009b","unstructured":"Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A (2009b) Subcortical elevation of metabolism in Parkinson\u2019s disease\u2014a critical reappraisal in the context of global mean normalization. Neuroimage 47(4):1514\u20131521","journal-title":"Neuroimage"},{"issue":"4","key":"165_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K, Arahata Y, Kato T, Gjedde A (2010) Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct Funct 214(4):303\u2013317","journal-title":"Brain Struct Funct"},{"key":"165_CR21","unstructured":"Borghammer P, Hansen SB, Eggers C, Chakravarty M, Vang K, Aanerud J, Hilker R, Heiss WD, Rodell A, Munk OL, Keator D, Gjedde A (2011a) Glucose metabolism in small subcortical structures in Parkinson\u2019s disease. Acta Neurologica Scandinavica. doi:10.1111\/j.1600-0404.2011.01556.x."},{"key":"165_CR189","unstructured":"Borghammer P, Cumming P, Ostergaard K, Gjedde A, Rodell A, Bailey CJ, Vafaee MS (2011b) Cerebral oxygen metabolism in patients with early Parkinson\u2019s disease. J Neurol Sci. [Epub ahead of print]"},{"issue":"2","key":"165_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"52","key":"165_CR23","doi-asserted-by":"crossref","first-page":"14320","DOI":"10.1523\/JNEUROSCI.3729-08.2008","volume":"28","author":"MN Braskie","year":"2008","unstructured":"Braskie MN, Wilcox CE, Landau SM, O\u2019Neil JP, Baker SL, Madison CM, Kluth JT, Jagust WJ (2008) Relationship of striatal dopamine synthesis capacity to age and cognition. J Neurosci 28(52):14320\u201314328","journal-title":"J Neurosci"},{"issue":"6","key":"165_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neurobiolaging.2004.07.014","volume":"26","author":"A Bruck","year":"2005","unstructured":"Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO (2005) Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson\u2019s disease. Neurobiol Aging 26(6):891\u2013898","journal-title":"Neurobiol Aging"},{"issue":"2","key":"165_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00392-006-0342-6","volume":"95","author":"J Bucerius","year":"2006","unstructured":"Bucerius J, Joe AY, Schmaljohann J, Gundisch D, Minnerop M, Biersack HJ, Wullner U, Reinhardt MJ (2006) Feasibility of 2-deoxy-2-[18F]fluoro-d-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo. Clin Res Cardiol 95(2):105\u2013109","journal-title":"Clin Res Cardiol"},{"issue":"Pt 4","key":"165_CR26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/brain\/118.4.951","volume":"118","author":"DJ Burn","year":"1995","unstructured":"Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ (1995) Striatal opioid receptor binding in Parkinson\u2019s disease, striatonigral degeneration and Steele\u2013Richardson\u2013Olszewski syndrome, a [11C]diprenorphine PET study. Brain 118(Pt 4):951\u2013958","journal-title":"Brain"},{"issue":"2B","key":"165_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","volume":"61","author":"RN Campos-Sousa","year":"2003","unstructured":"Campos-Sousa RN, Quagliato E, da Silva BB, de Carvalho RM Jr, Ribeiro SC, de Carvalho DF (2003) Urinary symptoms in Parkinson\u2019s disease: prevalence and associated factors. Arq Neuropsiquiatr 61(2B):359\u2013363","journal-title":"Arq Neuropsiquiatr"},{"issue":"196","key":"165_CR28","first-page":"1","volume":"56","author":"A Carlsson","year":"1962","unstructured":"Carlsson A, Falck B, Hillarp NA (1962) Cellular localization of brain monoamines. Acta Physiol Scand Suppl 56(196):1\u201328","journal-title":"Acta Physiol Scand Suppl"},{"issue":"2","key":"165_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(84)90117-3","volume":"322","author":"R Cash","year":"1984","unstructured":"Cash R, Ruberg M, Raisman R, Agid Y (1984) Adrenergic receptors in Parkinson\u2019s disease. Brain Res 322(2):269\u2013275","journal-title":"Brain Res"},{"issue":"1","key":"165_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.37.1.42","volume":"37","author":"R Cash","year":"1987","unstructured":"Cash R, Dennis T, L\u2019Heureux R, Raisman R, Javoy-Agid F, Scatton B (1987) Parkinson\u2019s disease and dementia: norepinephrine and dopamine in locus ceruleus. Neurology 37(1):42\u201346","journal-title":"Neurology"},{"issue":"4","key":"165_CR31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cne.902730409","volume":"273","author":"V Chan-Palay","year":"1988","unstructured":"Chan-Palay V (1988) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer\u2019s and Parkinson\u2019s disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 273(4):543\u2013557","journal-title":"J Comp Neurol"},{"issue":"3","key":"165_CR32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","volume":"287","author":"V Chan-Palay","year":"1989","unstructured":"Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression. J Comp Neurol 287(3):373\u2013392","journal-title":"J Comp Neurol"},{"issue":"6","key":"165_CR33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol 58(6):963\u2013967","journal-title":"Ann Neurol"},{"issue":"1","key":"165_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-510X(91)90193-B","volume":"106","author":"AV Cheng","year":"1991","unstructured":"Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK (1991) Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Sci 106(1):50\u201355","journal-title":"J Neurol Sci"},{"issue":"3","key":"165_CR35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(93)90240-G","volume":"54","author":"G Chinaglia","year":"1993","unstructured":"Chinaglia G, Landwehrmeyer B, Probst A, Palacios JM (1993) Serotoninergic terminal transporters are differentially affected in Parkinson\u2019s disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram. Neuroscience 54(3):691\u2013699","journal-title":"Neuroscience"},{"issue":"6","key":"165_CR36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","volume":"15","author":"F Cicchetti","year":"2002","unstructured":"Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 15(6):991\u2013998","journal-title":"Eur J Neurosci"},{"issue":"5","key":"165_CR37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.4475-07.2008","volume":"28","author":"R Cools","year":"2008","unstructured":"Cools R, Gibbs SE, Miyakawa A, Jagust W, D\u2019Esposito M (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28(5):1208\u20131212","journal-title":"J Neurosci"},{"issue":"4589","key":"165_CR38","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219(4589):1184\u20131190","journal-title":"Science"},{"issue":"2","key":"165_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(86)90048-0","volume":"63","author":"P Cumming","year":"1986","unstructured":"Cumming P, Von Krosigk M, Reiner PB, McGeer EG, Vincent SR (1986) Absence of adrenaline neurons in the guinea pig brain: a combined immunohistochemical and high-performance liquid chromatography study. Neurosci Lett 63(2):125\u2013130","journal-title":"Neurosci Lett"},{"issue":"3","key":"165_CR40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/syn.1077","volume":"41","author":"P Cumming","year":"2001","unstructured":"Cumming P, Munk OL, Doudet D (2001) Loss of metabolites from monkey striatum during PET with FDOPA. Synapse 41(3):212\u2013218","journal-title":"Synapse"},{"issue":"7","key":"165_CR41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/syn.20257","volume":"59","author":"P Cumming","year":"2006","unstructured":"Cumming P, Pedersen MD, Minuzzi L, Mezzomo K, Danielsen EH, Iversen P, Aagaard D, Keiding S, Munk OL, Finsen B (2006) Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography. Synapse 59(7):418\u2013426","journal-title":"Synapse"},{"issue":"6","key":"165_CR42","first-page":"956","volume":"40","author":"LJ Defebvre","year":"1999","unstructured":"Defebvre LJ, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, Steinling M, Destee A (1999) Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer\u2019s disease and idiopathic Parkinson\u2019s disease. J Nucl Med 40(6):956\u2013962","journal-title":"J Nucl Med"},{"issue":"1\u20132","key":"165_CR43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-510X(02)00079-5","volume":"199","author":"K Deguchi","year":"2002","unstructured":"Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, Kuriyama S (2002) Abnormalities of rate-corrected QT intervals in Parkinson\u2019s disease-a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 199(1\u20132):31\u201337","journal-title":"J Neurol Sci"},{"issue":"1","key":"165_CR44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/syn.20696","volume":"64","author":"YS Ding","year":"2010","unstructured":"Ding YS, Singhal T, Planeta-Wilson B, Gallezot JD, Nabulsi N, Labaree D, Ropchan J, Henry S, Williams W, Carson RE, Neumeister A, Malison RT (2010) PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S, S)-[(11)C]O-methylreboxetine and HRRT. Synapse 64(1):30\u201338","journal-title":"Synapse"},{"issue":"1","key":"165_CR45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroimage.2005.09.044","volume":"30","author":"DJ Doudet","year":"2006","unstructured":"Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P (2006) Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage 30(1):26\u201335","journal-title":"Neuroimage"},{"issue":"2","key":"165_CR46","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.neuroimage.2009.09.017","volume":"49","author":"J Dukart","year":"2010","unstructured":"Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, Becker G, Moller HE, Villringer A, Sabri O, Schroeter ML (2010) Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 49(2):1490\u20131495","journal-title":"Neuroimage"},{"issue":"3","key":"165_CR47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0197-4580(94)90028-0","volume":"15","author":"JL Eberling","year":"1994","unstructured":"Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson\u2019s disease without dementia. Neurobiol Aging 15(3):329\u2013335","journal-title":"Neurobiol Aging"},{"issue":"5","key":"165_CR48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14(5):783\u2013801","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20133","key":"165_CR49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-008-1347-9","volume":"202","author":"JR Ellis","year":"2009","unstructured":"Ellis JR, Nathan PJ, Villemagne VL, Mulligan RS, Saunder T, Young K, Smith CL, Welch J, Woodward M, Wesnes KA, Savage G, Rowe CC (2009) Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer\u2019s disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. Psychopharmacology (Berl) 202(1\u20133):79\u201391","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"165_CR50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(91)90667-K","volume":"552","author":"TM Engber","year":"1991","unstructured":"Engber TM, Susel Z, Kuo S, Gerfen CR, Chase TN (1991) Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res 552(1):113\u2013118","journal-title":"Brain Res"},{"issue":"Pt 3","key":"165_CR51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/119.3.823","volume":"119","author":"A Fernandez","year":"1996","unstructured":"Fernandez A, de Ceballos ML, Rose S, Jenner P, Marsden CD (1996) Alterations in peptide levels in Parkinson\u2019s disease and incidental Lewy body disease. Brain 119(Pt 3):823\u2013830","journal-title":"Brain"},{"issue":"22","key":"165_CR52","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","volume":"14","author":"F Fornai","year":"2007","unstructured":"Fornai F, di Poggio AB, Pellegrini A, Ruggieri S, Paparelli A (2007) Noradrenaline in Parkinson\u2019s disease: from disease progression to current therapeutics. Curr Med Chem 14(22):2330\u20132334","journal-title":"Curr Med Chem"},{"issue":"5","key":"165_CR53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jcbfm.1988.111","volume":"8","author":"PT Fox","year":"1988","unstructured":"Fox PT, Mintun MA, Reiman EM, Raichle ME (1988) Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8(5):642\u2013653","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 5","key":"165_CR54","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/111.5.1009","volume":"111","author":"RS Frackowiak","year":"1988","unstructured":"Frackowiak RS, Herold S, Petty RK, Morgan-Hughes JA (1988) The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain 111(Pt 5):1009\u20131024","journal-title":"Brain"},{"issue":"2","key":"165_CR55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","volume":"15","author":"PG Frisina","year":"2009","unstructured":"Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(2):144\u2013148","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 5","key":"165_CR56","first-page":"2253","volume":"114","author":"WP Gai","year":"1991","unstructured":"Gai WP, Halliday GM, Blumbergs PC, Geffen LB, Blessing WW (1991) Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson\u2019s disease. Brain 114(Pt 5):2253\u20132267","journal-title":"Brain"},{"issue":"4","key":"165_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410330405","volume":"33","author":"WP Gai","year":"1993","unstructured":"Gai WP, Geffen LB, Denoroy L, Blessing WW (1993) Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson\u2019s disease. Ann Neurol 33(4):357\u2013367","journal-title":"Ann Neurol"},{"issue":"3","key":"165_CR58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410300308","volume":"30","author":"P Gaspar","year":"1991","unstructured":"Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson\u2019s disease. Ann Neurol 30(3):365\u2013374","journal-title":"Ann Neurol"},{"issue":"2","key":"165_CR59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21(2):404\u2013412","journal-title":"Neurobiol Dis"},{"issue":"4","key":"165_CR60","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mds.10125","volume":"17","author":"M Ghaemi","year":"2002","unstructured":"Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, Heiss WD (2002) Monosymptomatic resting tremor and Parkinson\u2019s disease: a multitracer positron emission tomographic study. Mov Disord 17(4):782\u2013788","journal-title":"Mov Disord"},{"issue":"8","key":"165_CR61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58(8):1247\u20131255","journal-title":"Neurology"},{"issue":"2","key":"165_CR62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ana.410300211","volume":"30","author":"S Goto","year":"1991","unstructured":"Goto S, Hirano A (1991) Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson\u2019s disease. Ann Neurol 30(2):192\u2013196","journal-title":"Ann Neurol"},{"issue":"6\u20137","key":"165_CR63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuint.2010.03.001","volume":"56","author":"B Gulyas","year":"2010","unstructured":"Gulyas B, Brockschnieder D, Nag S, Pavlova E, Kasa P, Beliczai Z, Legradi A, Gulya K, Thiele A, Dyrks T, Halldin C (2010) The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer\u2019s disease: a post-mortem autoradiographic study. Neurochem Int 56(6\u20137):789\u2013798","journal-title":"Neurochem Int"},{"issue":"5","key":"165_CR64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","volume":"14","author":"M Guttman","year":"2007","unstructured":"Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ (2007) Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease. Eur J Neurol 14(5):523\u2013528","journal-title":"Eur J Neurol"},{"key":"165_CR65","unstructured":"Habeck CG (2010) Basics of multivariate analysis in neuroimaging data. J Vis Exp (41). pii. 1988. doi:10.3791\/1988"},{"issue":"11","key":"165_CR66","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","volume":"4","author":"C Henchcliffe","year":"2008","unstructured":"Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4(11):600\u2013609","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"165_CR185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.WCB.0000092831.44769.09","volume":"24","author":"R Hilker","year":"2004","unstructured":"Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, Lehrke R, Koulousakis A, Herholz K, Sturm V, Heiss WD (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24(1):7--16","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"165_CR67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wnf.0000154220.30263.0e","volume":"28","author":"LA Hosey","year":"2005","unstructured":"Hosey LA, Thompson JL, Metman LV, van den Munckhof P, Braun AR (2005) Temporal dynamics of cortical and subcortical responses to apomorphine in Parkinson disease: an H2(15)O PET study. Clin Neuropharmacol 28(1):18\u201327","journal-title":"Clin Neuropharmacol"},{"issue":"Pt 2","key":"165_CR68","first-page":"340","volume":"123","author":"MT Hu","year":"2000","unstructured":"Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ (2000) Cortical dysfunction in non-demented Parkinson\u2019s disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123(Pt 2):340\u2013352","journal-title":"Brain"},{"issue":"Pt 7","key":"165_CR69","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/awm086","volume":"130","author":"C Huang","year":"2007","unstructured":"Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson\u2019s disease. Brain 130(Pt 7):1834\u20131846","journal-title":"Brain"},{"issue":"10","key":"165_CR70","first-page":"1583","volume":"40","author":"Y Imon","year":"1999","unstructured":"Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N (1999) SPECT image analysis using statistical parametric mapping in patients with Parkinson\u2019s disease. J Nucl Med 40(10):1583\u20131589","journal-title":"J Nucl Med"},{"issue":"6","key":"165_CR71","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases. Neurology 52(6):1269\u20131271","journal-title":"Neurology"},{"issue":"12","key":"165_CR72","first-page":"2008","volume":"47","author":"S Jakobsen","year":"2006","unstructured":"Jakobsen S, Pedersen K, Smith DF, Jensen SB, Munk OL, Cumming P (2006) Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine. J Nucl Med 47(12):2008\u20132015","journal-title":"J Nucl Med"},{"issue":"5","key":"165_CR73","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1471-4159.1981.tb04672.x","volume":"37","author":"F Javoy-Agid","year":"1981","unstructured":"Javoy-Agid F, Ploska A, Agid Y (1981) Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains. J Neurochem 37(5):1218\u20131227","journal-title":"J Neurochem"},{"issue":"5","key":"165_CR74","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1471-4159.1986.tb00793.x","volume":"47","author":"P Jenner","year":"1986","unstructured":"Jenner P, Taquet H, Mauborgne A, Benoliel JT, Cesselin F, Rose S, Javoy-Agid F, Agid Y, Marsden CD (1986) Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine treatment of the common marmoset. J Neurochem 47(5):1548\u20131551","journal-title":"J Neurochem"},{"issue":"2","key":"165_CR75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2008.03.005","volume":"15","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO (2009) Impaired cognitive performance in Parkinson\u2019s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 15(2):88\u201393","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"165_CR76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","volume":"188","author":"A Kadir","year":"2006","unstructured":"Kadir A, Almkvist O, Wall A, Langstrom B, Nordberg A (2006) PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer\u2019s disease. Psychopharmacology (Berl) 188(4):509\u2013520","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"165_CR77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10286-004-0173-3","volume":"14","author":"M Kallio","year":"2004","unstructured":"Kallio M, Suominen K, Haapaniemi T, Sotaniemi K, Myllyla VV, Astafiev S, Tolonen U (2004) Nocturnal cardiac autonomic regulation in Parkinson\u2019s disease. Clin Auton Res 14(2):119\u2013124","journal-title":"Clin Auton Res"},{"issue":"1","key":"165_CR78","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2007.05.019","volume":"30","author":"G Kalpouzos","year":"2009","unstructured":"Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, Barre L, Constans JM, Viader F, Eustache F, Desgranges B (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30(1):112\u2013124","journal-title":"Neurobiol Aging"},{"issue":"9","key":"165_CR79","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","volume":"29","author":"A Kas","year":"2009","unstructured":"Kas A, Bottlaender M, Gallezot JD, Vidailhet M, Villafane G, Gregoire MC, Coulon C, Valette H, Dolle F, Ribeiro MJ, Hantraye P, Remy P (2009) Decrease of nicotinic receptors in the nigrostriatal system in Parkinson\u2019s disease. J Cereb Blood Flow Metab 29(9):1601\u20131608","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"165_CR80","first-page":"244","volume":"55","author":"K Kawabata","year":"1997","unstructured":"Kawabata K, Tachibana H (1997) Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson\u2019s disease using 123I-iomazenil SPECT. Nippon Rinsho 55(1):244\u2013248","journal-title":"Nippon Rinsho"},{"issue":"19","key":"165_CR81","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26(19):5256\u20135264","journal-title":"J Neurosci"},{"issue":"10","key":"165_CR82","first-page":"979","volume":"40","author":"S Kitamura","year":"1988","unstructured":"Kitamura S, Ujike T, Kuroki S, Sakamoto S, Soeda T, Iio M, Terashi A (1988) Cerebral blood flow and oxygen metabolism in patients with Parkinson\u2019s disease. No To Shinkei 40(10):979\u2013985","journal-title":"No To Shinkei"},{"issue":"47","key":"165_CR83","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1523\/JNEUROSCI.3706-09.2009","volume":"29","author":"M Koenigs","year":"2009","unstructured":"Koenigs M, Barbey AK, Postle BR, Grafman J (2009) Superior parietal cortex is critical for the manipulation of information in working memory. J Neurosci 29(47):14980\u201314986","journal-title":"J Neurosci"},{"issue":"10","key":"165_CR84","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1460-9568.2007.05580.x","volume":"25","author":"J Koerts","year":"2007","unstructured":"Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M (2007) Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson\u2019s disease. Eur J Neurosci 25(10):3132\u20133136","journal-title":"Eur J Neurosci"},{"issue":"8","key":"165_CR85","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cortex.2009.02.014","volume":"45","author":"J Koerts","year":"2009","unstructured":"Koerts J, Leenders KL, Brouwer WH (2009) Cognitive dysfunction in non-demented Parkinson\u2019s disease patients: controlled and automatic behavior. Cortex 45(8):922\u2013929","journal-title":"Cortex"},{"issue":"2","key":"165_CR86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000113470","volume":"38","author":"Y Koike","year":"1997","unstructured":"Koike Y, Takahashi A (1997) Autonomic dysfunction in Parkinson\u2019s disease. Eur Neurol 38(2):8\u201312","journal-title":"Eur Neurol"},{"issue":"8","key":"165_CR87","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0006-3223(95)00496-3","volume":"40","author":"VS Kostic","year":"1996","unstructured":"Kostic VS, Lecic D, Doder M, Marinkovic J, Filipovic S (1996) Prolactin and cortisol responses to fenfluramine in Parkinson\u2019s disease. Biol Psychiatry 40(8):769\u2013775","journal-title":"Biol Psychiatry"},{"issue":"6","key":"165_CR88","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1073858409338217","volume":"15","author":"Y Kumakura","year":"2009","unstructured":"Kumakura Y, Cumming P (2009) PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist 15(6):635\u2013650","journal-title":"Neuroscientist"},{"issue":"3","key":"165_CR89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.jcbfm.9600202","volume":"26","author":"Y Kumakura","year":"2006","unstructured":"Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P (2006) Dopamine storage capacity in caudate and putamen of patients with early Parkinson\u2019s disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 26(3):358\u2013370","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"165_CR90","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.neuroimage.2009.11.035","volume":"49","author":"Y Kumakura","year":"2010a","unstructured":"Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, Grunder G, Bartenstein P, Cumming P (2010a) Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson\u2019s disease. Neuroimage 49(4):2933\u20132939","journal-title":"Neuroimage"},{"issue":"3","key":"165_CR91","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neurobiolaging.2008.05.005","volume":"31","author":"Y Kumakura","year":"2010b","unstructured":"Kumakura Y, Vernaleken I, Buchholz HG, Borghammer P, Danielsen E, Grunder G, Heinz A, Bartenstein P, Cumming P (2010b) Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiol Aging 31(3):447\u2013463","journal-title":"Neurobiol Aging"},{"key":"165_CR92","doi-asserted-by":"crossref","unstructured":"la Fougere C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper H, Reader AEvans A, Thiel A (2010a) Where in vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [(18)F]flumazenil-PET. Neuroimage 56(3):951\u2013960","DOI":"10.1016\/j.neuroimage.2010.11.015"},{"issue":"4","key":"165_CR93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2967\/jnumed.109.071811","volume":"51","author":"C la Fougere","year":"2010b","unstructured":"la Fougere C, Popperl G, Levin J, Wangler B, Boning G, Uebleis C, Cumming P, Bartenstein P, Botzel K, Tatsch K (2010b) The value of the dopamine D2\/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med 51(4):581\u2013587","journal-title":"J Nucl Med"},{"issue":"8","key":"165_CR186","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00259-010-1436-y","volume":"37","author":"F Le Jeune","year":"2010","unstructured":"Le Jeune F, P\u00e9ron J, Grandjean D, Drapier S, Haegelen C, Garin E, Millet B, V\u00e9rin M (2010) Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur J Nucl Med Mol Imag 37(8):1512--1520","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"165_CR94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann Neurol 47(4):493\u2013503","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"165_CR95","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/108.1.171","volume":"108","author":"KL Leenders","year":"1985","unstructured":"Leenders KL, Wolfson L, Gibbs JM, Wise RJ, Causon R, Jones T, Legg NJ (1985) The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson\u2019s disease. Brain 108(Pt 1):171\u2013191","journal-title":"Brain"},{"issue":"Pt 1","key":"165_CR96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/113.1.27","volume":"113","author":"KL Leenders","year":"1990","unstructured":"Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, Gibbs JM, Wise RJ, Hatazawa J, Herold S et al (1990) Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 113(Pt 1):27\u201347","journal-title":"Brain"},{"issue":"3","key":"165_CR97","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1212\/WNL.41.3.365","volume":"41","author":"BE Levin","year":"1991","unstructured":"Levin BE, Llabre MM, Reisman S, Weiner WJ, Sanchez-Ramos J, Singer C, Brown MC (1991) Visuospatial impairment in Parkinson\u2019s disease. Neurology 41(3):365\u2013369","journal-title":"Neurology"},{"issue":"963","key":"165_CR98","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1126\/science.170.3963.1212","volume":"170","author":"K Lloyd","year":"1970","unstructured":"Lloyd K, Hornykiewicz O (1970) Parkinson\u2019s disease: activity of L-dopa decarboxylase in discrete brain regions. Science 170(963):1212\u20131213","journal-title":"Science"},{"issue":"7","key":"165_CR99","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1162\/jocn.2009.21087","volume":"21","author":"M Lotze","year":"2009","unstructured":"Lotze M, Reimold M, Heymans U, Laihinen A, Patt M, Halsband U (2009) Reduced ventrolateral fMRI response during observation of emotional gestures related to the degree of dopaminergic impairment in Parkinson disease. J Cogn Neurosci 21(7):1321\u20131331","journal-title":"J Cogn Neurosci"},{"issue":"1\u20136","key":"165_CR100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(82)90142-3","volume":"9","author":"SE Loughlin","year":"1982","unstructured":"Loughlin SE, Foote SL, Fallon JH (1982) Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull 9(1\u20136):287\u2013294","journal-title":"Brain Res Bull"},{"issue":"3","key":"165_CR101","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","volume":"27","author":"Y Ma","year":"2007","unstructured":"Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson\u2019s disease: test\u2013retest reproducibility. J Cereb Blood Flow Metab 27(3):597\u2013605","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"165_CR102","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0926-6410(02)00302-6","volume":"16","author":"M Makuuchi","year":"2003","unstructured":"Makuuchi M, Kaminaga T, Sugishita M (2003) Both parietal lobes are involved in drawing: a functional MRI study and implications for constructional apraxia. Brain Res Cogn Brain Res 16(3):338\u2013347","journal-title":"Brain Res Cogn Brain Res"},{"issue":"11","key":"165_CR103","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.40.11.1739","volume":"40","author":"S Malessa","year":"1990","unstructured":"Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y (1990) Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson\u2019s disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology 40(11):1739\u20131743","journal-title":"Neurology"},{"issue":"3","key":"165_CR104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mds.870030310","volume":"3","author":"JM Maloteaux","year":"1988a","unstructured":"Maloteaux JM, Laterre EC, Laduron PM, Javoy-Agid F, Agid Y (1988a) Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson\u2019s disease and progressive supranuclear palsy. Mov Disord 3(3):255\u2013262","journal-title":"Mov Disord"},{"issue":"2","key":"165_CR105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(88)90891-8","volume":"446","author":"JM Maloteaux","year":"1988b","unstructured":"Maloteaux JM, Luabeya MA, Vanisberg MA, Laterre EC, Laduron PM, Javoy-Agid F, Agid Y (1988b) Benzodiazepine receptors in normal human brain, in Parkinson\u2019s disease and in progressive supranuclear palsy. Brain Res 446(2):321\u2013332","journal-title":"Brain Res"},{"issue":"1","key":"165_CR106","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02252963","volume":"9","author":"RM Marie","year":"1995","unstructured":"Marie RM, Barre L, Rioux P, Allain P, Lechevalier B, Baron JC (1995) PET imaging of neocortical monoaminergic terminals in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 9(1):55\u201371","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"2","key":"165_CR107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(98)00928-8","volume":"260","author":"RM Marie","year":"1999","unstructured":"Marie RM, Barre L, Dupuy B, Viader F, Defer G, Baron JC (1999) Relationships between striatal dopamine denervation and frontal executive tests in Parkinson\u2019s disease. Neurosci Lett 260(2):77\u201380","journal-title":"Neurosci Lett"},{"issue":"2","key":"165_CR108","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004010100372","volume":"102","author":"PM Mattila","year":"2001","unstructured":"Mattila PM, Roytta M, Lonnberg P, Marjamaki P, Helenius H, Rinne JO (2001) Choline acetytransferase activity and striatal dopamine receptors in Parkinson\u2019s disease in relation to cognitive impairment. Acta Neuropathol 102(2):160\u2013166","journal-title":"Acta Neuropathol"},{"issue":"2\u20133","key":"165_CR109","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","volume":"41","author":"M Mavridis","year":"1991","unstructured":"Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson\u2019s disease. Neuroscience 41(2\u20133):507\u2013523","journal-title":"Neuroscience"},{"issue":"5","key":"165_CR110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D (2003) Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administration. Ann Neurol 54(5):599\u2013604","journal-title":"Ann Neurol"},{"issue":"2","key":"165_CR111","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051102","volume":"146","author":"MA Mehta","year":"1999","unstructured":"Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson\u2019s disease. Psychopharmacology (Berl) 146(2):162\u2013174","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"165_CR112","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-0947-0","volume":"196","author":"MA Mehta","year":"2008","unstructured":"Mehta MA, Montgomery AJ, Kitamura Y, Grasby PM (2008) Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers. Psychopharmacology (Berl) 196(1):157\u2013165","journal-title":"Psychopharmacology (Berl)"},{"issue":"Pt 3","key":"165_CR113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/brain\/awq377","volume":"134","author":"TR Melzer","year":"2011","unstructured":"Melzer TR, Watts R, Macaskill MR, Pearson JF, Rueger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ (2011) Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson\u2019s disease. Brain 134(Pt 3):845\u2013855","journal-title":"Brain"},{"issue":"4","key":"165_CR114","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","volume":"19","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19(4):541\u2013547","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"165_CR115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004647-199605000-00005","volume":"16","author":"JR Moeller","year":"1996","unstructured":"Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady C, Pietrini P, Eidelberg D (1996) The metabolic topography of normal aging. J Cereb Blood Flow Metab 16(3):385\u2013398","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"165_CR116","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","volume":"864","author":"KP Mohanakumar","year":"2000","unstructured":"Mohanakumar KP, Muralikrishnan D, Thomas B (2000) Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. Brain Res 864(2):281\u2013290","journal-title":"Brain Res"},{"issue":"3","key":"165_CR117","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ (2008) Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis 29(3):381\u2013390","journal-title":"Neurobiol Dis"},{"issue":"8","key":"165_CR118","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovic","year":"2005","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239\u20131245","journal-title":"Neurology"},{"issue":"2","key":"165_CR119","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neuroimage.2004.01.030","volume":"22","author":"A Nagano-Saito","year":"2004","unstructured":"Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, Yamada T, Iwai K, Hatano K, Kawasumi Y, Kachi T, Dagher A, Ito K (2004) Cognitive- and motor-related regions in Parkinson\u2019s disease: FDOPA and FDG PET studies. Neuroimage 22(2):553\u2013561","journal-title":"Neuroimage"},{"issue":"2","key":"165_CR120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","volume":"75","author":"T Nagatsu","year":"1977","unstructured":"Nagatsu T, Kato T, Numata Y, Ikuta K, Sano M (1977) Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta 75(2):221\u2013232","journal-title":"Clin Chim Acta"},{"issue":"3","key":"165_CR121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-510X(85)90135-2","volume":"69","author":"C Nahmias","year":"1985","unstructured":"Nahmias C, Garnett ES, Firnau G, Lang A (1985) Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci 69(3):223\u2013230","journal-title":"J Neurol Sci"},{"issue":"2","key":"165_CR122","first-page":"S30","volume":"64","author":"JA Obeso","year":"2008","unstructured":"Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temino B, Mena-Segovia J, Rodriguez M, Olanow CW (2008) The basal ganglia in Parkinson\u2019s disease: current concepts and unexplained observations. Ann Neurol 64(2):S30\u2013S46","journal-title":"Ann Neurol"},{"issue":"4","key":"165_CR123","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00696560","volume":"34","author":"E Ohama","year":"1976","unstructured":"Ohama E, Ikuta F (1976) Parkinson\u2019s disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 34(4):311\u2013319","journal-title":"Acta Neuropathol"},{"issue":"4","key":"165_CR124","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0197-4580(97)00034-1","volume":"18","author":"TG Ohm","year":"1997","unstructured":"Ohm TG, Busch C, Bohl J (1997) Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging 18(4):393\u2013399","journal-title":"Neurobiol Aging"},{"issue":"5","key":"165_CR125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03164869","volume":"13","author":"M Ohyama","year":"1999","unstructured":"Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, Ishii K, Toyama H, Oda K, Katayama Y (1999) Preserved benzodiazepine receptors in Alzheimer\u2019s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 13(5):309\u2013315","journal-title":"Ann Nucl Med"},{"issue":"7","key":"165_CR126","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.37.7.1173","volume":"37","author":"L Orskov","year":"1987","unstructured":"Orskov L, Jakobsen J, Dupont E, de Fine Olivarius B, Christensen NJ (1987) Autonomic function in parkinsonian patients relates to duration of disease. Neurology 37(7):1173\u20131178","journal-title":"Neurology"},{"issue":"2","key":"165_CR127","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57(2):168\u2013175","journal-title":"Ann Neurol"},{"issue":"3","key":"165_CR128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuint.2010.12.007","volume":"58","author":"M Palner","year":"2010","unstructured":"Palner M, Kjaerby C, Knudsen GM, Cumming P (2010) Effects of unilateral 6-OHDA lesions on [(3)H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat. Neurochem Int 58(3):243\u2013247","journal-title":"Neurochem Int"},{"issue":"6","key":"165_CR129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50(6):743\u2013755","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"165_CR130","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/brain\/awq268","volume":"133","author":"N Pavese","year":"2010","unstructured":"Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ (2010) Fatigue in Parkinson\u2019s disease is linked to striatal and limbic serotonergic dysfunction. Brain 133(11):3434\u20133443","journal-title":"Brain"},{"issue":"1","key":"165_CR131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-4886(95)90012-8","volume":"131","author":"I Perez-Otano","year":"1995","unstructured":"Perez-Otano I, Luquin MR, Oset C, Herrero MT, Kupsch A, Oertel W, Obeso JA, Del Rio J (1995) Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain. Exp Neurol 131(1):108\u2013113","journal-title":"Exp Neurol"},{"issue":"3","key":"165_CR132","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-3940(84)90402-6","volume":"51","author":"EK Perry","year":"1984","unstructured":"Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE (1984) Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer\u2019s disease: comparisons with Parkinson\u2019s disease. Neurosci Lett 51(3):353\u2013357","journal-title":"Neurosci Lett"},{"key":"165_CR133","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","volume":"640","author":"EK Perry","year":"1991","unstructured":"Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D et al (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson\u2019s disease, and Alzheimer\u2019s disease. Ann N Y Acad Sci 640:197\u2013202","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"165_CR134","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","volume":"42","author":"P Piccini","year":"1997","unstructured":"Piccini P, Weeks RA, Brooks DJ (1997) Alterations in opioid receptor binding in Parkinson\u2019s disease patients with levodopa-induced dyskinesias. Ann Neurol 42(5):720\u2013726","journal-title":"Ann Neurol"},{"issue":"5","key":"165_CR135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuint.2006.03.013","volume":"49","author":"C Pifl","year":"2006","unstructured":"Pifl C, Hornykiewicz O (2006) Dopamine turnover is upregulated in the caudate\/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem Int 49(5):519\u2013524","journal-title":"Neurochem Int"},{"issue":"21","key":"165_CR136","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","volume":"75","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P (2010) Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75(21):1920\u20131927","journal-title":"Neurology"},{"issue":"10","key":"165_CR137","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/jcbfm.2008.63","volume":"28","author":"WJ Powers","year":"2008","unstructured":"Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS (2008) Cerebral mitochondrial metabolism in early Parkinson\u2019s disease. J Cereb Blood Flow Metab 28(10):1754\u20131760","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"165_CR138","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.44.1.84","volume":"44","author":"JS Purba","year":"1994","unstructured":"Purba JS, Hofman MA, Swaab DF (1994) Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson\u2019s disease. Neurology 44(1):84\u201389","journal-title":"Neurology"},{"issue":"11","key":"165_CR139","first-page":"1769","volume":"47","author":"DM Raffel","year":"2006","unstructured":"Raffel DM, Koeppe RA, Little R, Wang CN, Liu S, Junck L, Heumann M, Gilman S (2006) PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med 47(11):1769\u20131777","journal-title":"J Nucl Med"},{"issue":"11","key":"165_CR140","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/mds.22158","volume":"23","author":"I Rektorova","year":"2008","unstructured":"Rektorova I, Srovnalova H, Kubikova R, Prasek J (2008) Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson\u2019s disease. Mov Disord 23(11):1580\u20131587","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"165_CR141","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128(Pt 6):1314\u20131322","journal-title":"Brain"},{"issue":"13","key":"165_CR142","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/mds.23239","volume":"25","author":"J Rodriguez-Ferreiro","year":"2010","unstructured":"Rodriguez-Ferreiro J, Cuetos F, Herrera E, Menendez M, Ribacoba R (2010) Cognitive impairment in Parkinson\u2019s disease without dementia. Mov Disord 25(13):2136\u20132141","journal-title":"Mov Disord"},{"issue":"2","key":"165_CR143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","volume":"74","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger KS, Weinshenker D (2007) Norepinephrine: the redheaded stepchild of Parkinson\u2019s disease. Biochem Pharmacol 74(2):177\u2013190","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"165_CR144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-510X(01)00521-4","volume":"187","author":"R Sakakibara","year":"2001","unstructured":"Sakakibara R, Shinotoh H, Uchiyama T, Yoshiyama M, Hattori T, Yamanishi T (2001) SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson\u2019s disease with urinary dysfunction. J Neurol Sci 187(1\u20132):55\u201359","journal-title":"J Neurol Sci"},{"issue":"2","key":"165_CR145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.74.2.268","volume":"74","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, Yamanishi T, Hattori T (2003) Colonic transit time and rectoanal videomanometry in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74(2):268\u2013272","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"165_CR146","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410290602","volume":"29","author":"CB Saper","year":"1991","unstructured":"Saper CB, Sorrentino DM, German DC, de Lacalle S (1991) Medullary catecholaminergic neurons in the normal human brain and in Parkinson\u2019s disease. Ann Neurol 29(6):577\u2013584","journal-title":"Ann Neurol"},{"issue":"2","key":"165_CR147","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease. Brain Res 275(2):321\u2013328","journal-title":"Brain Res"},{"issue":"1","key":"165_CR148","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(86)91446-0","volume":"380","author":"B Scatton","year":"1986","unstructured":"Scatton B, Dennis T, L\u2019Heureux R, Monfort JC, Duyckaerts C, Javoy-Agid F (1986) Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Res 380(1):181\u2013185","journal-title":"Brain Res"},{"issue":"2","key":"165_CR149","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.46.2.388","volume":"46","author":"CH Schenck","year":"1996","unstructured":"Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46(2):388\u2013393","journal-title":"Neurology"},{"issue":"1\u20132","key":"165_CR150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(90)90108-N","volume":"534","author":"JS Schneider","year":"1990","unstructured":"Schneider JS (1990) Chronic exposure to low doses of MPTP II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys. Brain Res 534(1\u20132):25\u201336","journal-title":"Brain Res"},{"issue":"2","key":"165_CR190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0022-510X(67)90140-2","volume":"5","author":"G Selby","year":"1968","unstructured":"Selby G (1968) Stereotactic surgery for the relief of Parkinson's disease. 2. An analysis of the results in a series of 303 patients (413 operations). J Neurol Sci 5(2):343--375","journal-title":"J Neurol Sci"},{"issue":"1","key":"165_CR151","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","volume":"639","author":"K Shannak","year":"1994","unstructured":"Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O (1994) Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects. Brain Res 639(1):33\u201341","journal-title":"Brain Res"},{"issue":"1","key":"165_CR152","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1460-9568.2006.04903.x","volume":"24","author":"T Siessmeier","year":"2006","unstructured":"Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rosch F, Cumming P, Mann K, Bartenstein P, Heinz A (2006) Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Eur J Neurosci 24(1):305\u2013313","journal-title":"Eur J Neurosci"},{"issue":"8979","key":"165_CR153","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","volume":"346","author":"C Singaram","year":"1995","unstructured":"Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM (1995) Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation. Lancet 346(8979):861\u2013864","journal-title":"Lancet"},{"issue":"3","key":"165_CR154","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000116810","volume":"32","author":"C Singer","year":"1992","unstructured":"Singer C, Weiner WJ, Sanchez-Ramos JR (1992) Autonomic dysfunction in men with Parkinson\u2019s disease. Eur Neurol 32(3):134\u2013140","journal-title":"Eur Neurol"},{"issue":"8","key":"165_CR155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/syn.20262","volume":"59","author":"DF Smith","year":"2006","unstructured":"Smith DF, Dyve S, Minuzzi L, Jakobsen S, Munk OL, Marthi K, Cumming P (2006) Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse 59(8):463\u2013471","journal-title":"Synapse"},{"issue":"1","key":"165_CR156","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-009-1587-3","volume":"206","author":"DF Smith","year":"2009","unstructured":"Smith DF, Stork BS, Wegener G, Ashkanian M, Jakobsen S, Bender D, Audrain H, Vase KH, Hansen SB, Videbech P, Rosenberg R (2009) [11C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging. Psychopharmacology (Berl) 206(1):133\u2013140","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"165_CR157","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897\u2013916","journal-title":"J Neurochem"},{"issue":"2B","key":"165_CR158","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/S0004-282X2007000300008","volume":"65","author":"F Stella","year":"2007","unstructured":"Stella F, Gobbi LT, Gobbi S, Oliani MM, Tanaka K, Pieruccini-Faria F (2007) Early impairment of cognitive functions in Parkinson\u2019s disease. Arq Neuropsiquiatr 65(2B):406\u2013410","journal-title":"Arq Neuropsiquiatr"},{"issue":"Pt 1","key":"165_CR159","first-page":"126","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128(Pt 1):126\u2013137","journal-title":"Brain"},{"issue":"1\u20132","key":"165_CR160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","volume":"240","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, Urashima M, Inoue K (2006) Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson\u2019s disease. J Neurol Sci 240(1\u20132):15\u201319","journal-title":"J Neurol Sci"},{"issue":"12","key":"165_CR161","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/mds.10586","volume":"18","author":"L Swinn","year":"2003","unstructured":"Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N (2003) Sweating dysfunction in Parkinson\u2019s disease. Mov Disord 18(12):1459\u20131463","journal-title":"Mov Disord"},{"issue":"46","key":"165_CR191","doi-asserted-by":"crossref","first-page":"12032","DOI":"10.1523\/JNEUROSCI.3446-08.2008","volume":"28","author":"H Takahashi","year":"2008","unstructured":"Takahashi H, Kato M, Takano H, Arakawa R, Okumura M, Otsuka T, Kodaka F, Hayashi M, Okubo Y, Ito H, Suhara T (2008) Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions. J Neurosci 28(46):12032--12038","journal-title":"J Neurosci"},{"issue":"1","key":"165_CR162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(99)00142-2","volume":"167","author":"S Takahashi","year":"1999","unstructured":"Takahashi S, Tohgi H, Yonezawa H, Obara S, Yamazaki E (1999) The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson\u2019s disease. J Neurol Sci 167(1):56\u201361","journal-title":"J Neurol Sci"},{"issue":"2","key":"165_CR163","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","volume":"9","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 9(2):149\u2013158","journal-title":"Lancet Neurol"},{"issue":"22","key":"165_CR164","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/0006-2952(83)90353-2","volume":"32","author":"LJ Thal","year":"1983","unstructured":"Thal LJ, Sharpless NS, Hirschhorn ID, Horowitz SG, Makman MH (1983) Striatal met-enkephalin concentration increases following nigrostriatal denervation. Biochem Pharmacol 32(22):3297\u20133301","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"165_CR165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(93)90111-W","volume":"150","author":"H Tohgi","year":"1993","unstructured":"Tohgi H, Abe T, Takahashi S, Takahashi J, Hamato H (1993) Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 150(1):71\u201374","journal-title":"Neurosci Lett"},{"issue":"2","key":"165_CR187","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuroimage.2004.02.019","volume":"22","author":"MS Vafaee","year":"2004","unstructured":"Vafaee MS, \u00d8stergaard K, Sunde N, Gjedde A, Dupont E, Cumming P (2004) Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation. Neuroimage 22(2):966--974","journal-title":"Neuroimage"},{"issue":"3","key":"165_CR166","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.parkreldis.2007.08.011","volume":"14","author":"M van Beilen","year":"2008","unstructured":"van Beilen M, Portman AT, Kiers HA, Maguire RP, Kaasinen V, Koning M, Pruim J, Leenders KL (2008) Striatal FDOPA uptake and cognition in advanced non-demented Parkinson\u2019s disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord 14(3):224\u2013228","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"165_CR167","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00259-009-1353-0","volume":"37","author":"N Van Camp","year":"2010","unstructured":"Van Camp N, Boisgard R, Kuhnast B, Theze B, Viel T, Gregoire MC, Chauveau F, Boutin H, Katsifis A, Dolle F, Tavitian B (2010) In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C]CLINME and [(11)C]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging 37(5):962\u2013972","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"165_CR168","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hbm.20325","volume":"28","author":"I Vernaleken","year":"2007","unstructured":"Vernaleken I, Buchholz HG, Kumakura Y, Siessmeier T, Stoeter P, Bartenstein P, Cumming P, Grunder G (2007) \u2018Prefrontal\u2019 cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation. Hum Brain Mapp 28(10):931\u2013939","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"165_CR169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02252658","volume":"7","author":"R Volpi","year":"1994","unstructured":"Volpi R, Caffarra P, Scaglioni A, Maestri D, Chiodera P, Coiro V (1994) Restoration of ACTH\/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 7(1):1\u201311","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"2","key":"165_CR170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000119394","volume":"35","author":"R Volpi","year":"1997a","unstructured":"Volpi R, Caffarra P, Boni S, Scaglioni A, Malvezzi L, Saginario A, Chiodera P, Coiro V (1997a) ACTH\/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. Neuropsychobiology 35(2):73\u201378","journal-title":"Neuropsychobiology"},{"issue":"2","key":"165_CR171","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000119395","volume":"35","author":"R Volpi","year":"1997b","unstructured":"Volpi R, Caffarra P, Scaglioni A, Boni S, Saginario A, Chiodera P, Coiro V (1997b) Defective 5-HT 1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson\u2019s disease. Neuropsychobiology 35(2):79\u201383","journal-title":"Neuropsychobiology"},{"key":"165_CR188","doi-asserted-by":"crossref","unstructured":"von Economo C (1931) Encephalitis lethargica. Its sequelae and treatment.\n(trans: Newman KO). Oxford University Press, London","DOI":"10.1097\/00007611-193111000-00029"},{"issue":"3","key":"165_CR172","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s004010050705","volume":"94","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke\u2019s column in Parkinson\u2019s disease. Acta Neuropathol 94(3):287\u2013289","journal-title":"Acta Neuropathol"},{"issue":"3","key":"165_CR173","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/1097-0193(200011)11:3<131::AID-HBM10>3.0.CO;2-M","volume":"11","author":"B Weder","year":"2000","unstructured":"Weder B, Azari NP, Knorr U, Seitz RJ, Keel A, Nienhusmeier M, Maguire RP, Leenders KL, Ludin HP (2000) Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson\u2019s disease. Hum Brain Mapp 11(3):131\u2013145","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"165_CR174","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cne.20745","volume":"492","author":"E Weihe","year":"2005","unstructured":"Weihe E, Schutz B, Hartschuh W, Anlauf M, Schafer MK, Eiden LE (2005) Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. J Comp Neurol 492(3):370\u2013379","journal-title":"J Comp Neurol"},{"issue":"2","key":"165_CR175","first-page":"227","volume":"46","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease. J Nucl Med 46(2):227\u2013232","journal-title":"J Nucl Med"},{"issue":"5","key":"165_CR176","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/13803390590954236","volume":"28","author":"CJ Whittington","year":"2006","unstructured":"Whittington CJ, Podd J, Stewart-Williams S (2006) Memory deficits in Parkinson\u2019s disease. J Clin Exp Neuropsychol 28(5):738\u2013754","journal-title":"J Clin Exp Neuropsychol"},{"issue":"Pt 7","key":"165_CR177","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","volume":"130","author":"CH Williams-Gray","year":"2007","unstructured":"Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort. Brain 130(Pt 7):1787\u20131798","journal-title":"Brain"},{"issue":"7","key":"165_CR178","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/nau.20054","volume":"23","author":"K Winge","year":"2004","unstructured":"Winge K, Werdelin LM, Nielsen KK, Stimpel H (2004) Effects of dopaminergic treatment on bladder function in Parkinson\u2019s disease. Neurourol Urodyn 23(7):689\u2013696","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"165_CR179","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2005.01087.x","volume":"12","author":"K Winge","year":"2005","unstructured":"Winge K, Friberg L, Werdelin L, Nielsen KK, Stimpel H (2005) Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson\u2019s disease. Eur J Neurol 12(11):842\u2013850","journal-title":"Eur J Neurol"},{"issue":"3","key":"165_CR180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2010.08.037","volume":"484","author":"KK Wong","year":"2010","unstructured":"Wong KK, Muller ML, Kuwabara H, Studenski SA, Bohnen NI (2010) Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett 484(3):163\u2013167","journal-title":"Neurosci Lett"},{"issue":"1","key":"165_CR181","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2008.07.015","volume":"44","author":"I Yakushev","year":"2009","unstructured":"Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, Peters J, Bartenstein P, Lieb K, Schreckenberger M (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer\u2019s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44(1):43\u201350","journal-title":"Neuroimage"},{"issue":"1","key":"165_CR182","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M (1998) Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155(1):60\u201367","journal-title":"J Neurol Sci"},{"issue":"3","key":"165_CR183","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2003","unstructured":"Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60(3):337\u2013341","journal-title":"Arch Neurol"},{"issue":"5","key":"165_CR184","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.43.5.986","volume":"43","author":"RM Zweig","year":"1993","unstructured":"Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson\u2019s disease. Neurology 43(5):986\u2013991","journal-title":"Neurology"}],"container-title":["Current Topics in Behavioral Neurosciences","Brain Imaging in Behavioral Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2011_165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T17:43:54Z","timestamp":1676742234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2011_165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642287107","9783642287114"],"references-count":191,"URL":"https:\/\/doi.org\/10.1007\/7854_2011_165","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"28 October 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}